CRESCENDO BIOLOG LTD has a total of 19 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), United Kingdom and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are OPEN MONOCLONAL TECH INC, REGENERON FARMASYUTIKALZ INK and OMT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United Kingdom | 4 | |
#3 | United States | 4 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Animal care | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Combinatorial chemistry | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Teng Yumin | 6 |
#2 | Romanos Mike | 5 |
#3 | Edwards Bryan | 5 |
#4 | Mcguinness Brian | 5 |
#5 | Brueggemann Marianne | 4 |
#6 | Lashmar Ulla | 3 |
#7 | Zou Xiangang | 3 |
#8 | Young Joyce | 3 |
#9 | Sandal Thomas | 3 |
#10 | Edwards Brian | 2 |
Publication | Filing date | Title |
---|---|---|
GB201607968D0 | Chimeric antigen receptor | |
WO2016113555A1 | Anti-il-17ra immunoglobulin single heavy variable domain antibodies | |
CN107108730A | IL 17A associated proteins | |
GB201600559D0 | Therapeutic molecules | |
GB201500464D0 | Method of producing optimised therapeutic molecules | |
GB201301845D0 | Antibody delivery | |
US2010122358A1 | H-Chain-only antibodies |